This brand name is authorized in Nigeria.
The drug ETHIFLOZIN contains one active pharmaceutical ingredient (API):
1
|
UNII
43B2M34G2V - FLUCLOXACILLIN
|
|
Flucloxacillin is an isoxazolyl penicillin of the β-lactam group of antibiotics which exerts a bactericidal effect upon many Gram-positive organisms including β-lactamase-producing staphylococci and streptococci. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100464 | Capsule | ETHIFLOZIN Capsules 500mg CAP 500 mg 10 X 10 | 191 NF-PP-242476 ETHIFLOZIN Capsules 500mg Flucloxacillin 500mg Flucloxacillin 500mg, Exe. Colloidal Anhydrous Silica, Magnesium Stearate Drugs Imported Products 10X10 POM 1 12/8/2021 SK MEDICINES LIMITED, KOFO ABAYOMI STREET, VICTORIA ISLAND LAGOS 8037777070 info@skmedicines.com Medreich Limited unit 1, 12th , mile , old Madras road.Virgonagar,Bangalore . 560049, India | 06/07/2023 |
| A4-100465 | Suspension | ETHIFLOZIN Suspension 125mg SUSP 125 mg 1 X 100ML | 193 NF-PP-242482 ETHIFLOZIN Suspension 125mg Flucloxacillin Suspension 125mg When reconstituted each 5 ml contains 125 mg flucloxacillin, as Flucloxacillin sodium BP. Ethiflozin Oral Solution 125 mg/5 ml contain sodium benzoate and sucrose. Drugs Imported Products 1x100ml POM 1 12/8/2021 SK MEDICINES LIMITED, KOFO ABAYOMI STREET, VICTORIA ISLAND LAGOS 8037777070 info@skmedicines.com Medreich Limited unit 1, 12th , mile , old Madras road.Virgonagar,Bangalore . 560049, India | 06/07/2023 |
| A4-100466 | Suspension | ETHIFLOZIN Suspension 250mg SUSP 250 mg 1 X 100ML | 192 NF-PP-242490 ETHIFLOZIN Suspension 250mg Flucloxacillin Suspension 250mg Flucloxacillin 250mg and Excepients contains sodium methyl hydroxy benzoate, sodium propyl hydroxy benzoate & sucrose Drugs Imported Products 1x100ml POM 1 12/8/2021 SK MEDICINES LIMITED, KOFO ABAYOMI STREET, VICTORIA ISLAND LAGOS 8037777070 info@skmedicines.com Medreich Limited unit 1, 12th , mile , old Madras road.Virgonagar,Bangalore . 560049, India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01CF05 | Flucloxacillin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CF Beta-lactamase resistant penicillins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100464, A4-100465, A4-100466 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.